What is the Dr. Agarwal's Health Care Ltd share price today?

The share price of NSE:AGARWALEYE-EQ on 01 Oct 2026 (as of 15:02:59 IST) is ₹486.65.

What is the NSE:AGARWALEYE-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:AGARWALEYE-EQ 52 week high low range shows a high of ₹568 and a low of ₹401.

What is the Dr. Agarwal's Health Care Ltd market cap?

As on 01 Oct 2026, Dr. Agarwal's Health Care Ltd market cap is ₹152125000000.

What is the shareholding pattern of Dr. Agarwal's Health Care Ltd Stock?

The shareholding pattern of Dr. Agarwal's Health Care Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 32.34% Foreign Institutional Investors (FII): 37.91% Domestic Institutional Investors (DII): 1.7% Mutual Funds: 6.02% Retail & Others: 22.03% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Dr. Agarwal's Health Care Ltd?

The Price-to-Earnings (PE) ratio of Dr. Agarwal's Health Care Ltd is 102.531, and the Price-to-Book (PB) ratio is 6.3908, as on 01 Oct 2026.

Dr. Agarwal's Health Care Share Price

486.85+0.00 (+0.54%)

-0.72% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+0.54%

1 Week

+0.08%

1 Month

-6.06%

3 Month

+0.26%

6 Month

+11.70%

YTD

-4.23%

1 Year

-0.72%

5 Year

10 Year

Max

+21.11%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

474.20

471.15

470.00

420.00

401.00

High

488.80

492.00

523.80

567.75

568.00

About

Dr. Agarwal's Health Care provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lens and accessories, Read more

Hospital & Healthcare Services

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

APOLLOHOSPNSE

MAXHEALTHNSE

MANIPALHOSNSE

ASTERDMNSE

FORTISNSE

MEDANTANSE

NHNSE

LALPATHLABNSE

KIMSNSE

AGARWALEYENSE

LTP

1W Low

1W High

Market cap (₹)

7914.5-219 (-2.69%)

7806

8076

1,15,172Cr

902.5-38.45 (-4.09%)

892.25

939.80

89,214Cr

690.5-5.5 (-0.79%)

662.35

701.30

87,775Cr

684.7-24.2 (-3.41%)

674.10

708

60,233Cr

764-21 (-2.68%)

756.30

785.75

57,754Cr

1300.8-56.5 (-4.16%)

1282

1369.10

35,806Cr

1723.8-17.6 (-1.01%)

1709.60

1749.60

35,189Cr

1964.2-40.9 (-2.04%)

1945.90

2026

33,078Cr

693.4-42.85 (-5.82%)

691

747.85

29,482Cr

487+0.55 (0.11%)

474.20

492

15,339Cr

Dr. Agarwal's Health Care Share Price

486.85+0.00 (+0.54%)

-0.72% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years35%

3 years27%

Last year22%

Compounded Profit Growth

10 years-

5 years-

3 years12%

Last year52%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year-1%

Return on Equity

10 years5%

5 years14%

3 years8%

Last year9%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	35%	27%	22%
-	-	12%	52%
-	-	-	-1%
5%	14%	8%	9%

Peer Comparison

Symbol

APOLLOHOSP

MAXHEALTH

MANIPALHOS

ASTERDM

FORTIS

MEDANTA

LALPATHLAB

KIMS

AGARWALEYE

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
7,914.5	₹115172 Cr	55.12	40.39	207.67	₹1942 Cr
902.5	₹89214 Cr	61.23	3.31	19.84	₹1442 Cr
690.5	₹87775 Cr	98.37	1.96	11.95	₹892 Cr
684.7	₹60233 Cr	189.01	0.31	6.76	₹388 Cr
764	₹57754 Cr	55.11	3.53	20.1	₹1042 Cr
1,300.8	₹35806 Cr	64.38	5.91	29.85	₹556 Cr
1,723.8	₹35189 Cr	43.12	10.14	65.36	₹806 Cr
1,964.2	₹33078 Cr	61.04	10.11	42.51	₹505 Cr
693.4	₹29482 Cr	144.31	1.04	12.74	₹241 Cr
487	₹15339 Cr	103.39	1.43	13.88	₹133 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
₹614 Cr	₹564 Cr	₹530 Cr	₹499 Cr	₹487 Cr	₹460 Cr	₹431 Cr	₹417 Cr	₹403 Cr	₹349 Cr	₹333 Cr
₹6 Cr	₹13 Cr	₹11 Cr	₹8 Cr	₹13 Cr	₹15 Cr	₹13 Cr	₹12 Cr	₹6 Cr	₹20 Cr	₹12 Cr
₹620 Cr	₹577 Cr	₹540 Cr	₹507 Cr	₹501 Cr	₹476 Cr	₹443 Cr	₹428 Cr	₹409 Cr	₹369 Cr	₹345 Cr
₹522 Cr	₹479 Cr	₹455 Cr	₹430 Cr	₹423 Cr	₹390 Cr	₹374 Cr	₹367 Cr	₹355 Cr	₹288 Cr	₹286 Cr
₹177 Cr	₹174 Cr	₹155 Cr	₹144 Cr	₹141 Cr	₹146 Cr	₹128 Cr	₹119 Cr	₹110 Cr	₹127 Cr	₹101 Cr
₹23 Cr	₹22 Cr	₹21 Cr	₹23 Cr	₹25 Cr	₹25 Cr	₹28 Cr	₹28 Cr	₹27 Cr	₹27 Cr	₹22 Cr
₹75 Cr	₹77 Cr	₹65 Cr	₹54 Cr	₹54 Cr	₹59 Cr	₹41 Cr	₹33 Cr	₹27 Cr	₹54 Cr	₹36 Cr
₹55 Cr	₹50 Cr	₹44 Cr	₹36 Cr	₹38 Cr	₹43 Cr	₹28 Cr	₹21 Cr	₹18 Cr	₹41 Cr	₹23 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Less Impairment of Assets

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
—	—	—	—	—	—	—
₹32 Cr	₹32 Cr	₹9 Cr	₹8 Cr	₹7 Cr	₹7 Cr	₹7 Cr
₹12 Cr	₹10 Cr	₹6 Cr	₹2 Cr	₹0	₹0	₹0
₹1982 Cr	₹1825 Cr	₹1324 Cr	₹620 Cr	₹206 Cr	₹177 Cr	₹242 Cr
₹1982 Cr	₹1825 Cr	₹1324 Cr	₹620 Cr	₹206 Cr	₹177 Cr	₹242 Cr
₹2025 Cr	₹1867 Cr	₹1339 Cr	₹630 Cr	₹212 Cr	₹184 Cr	₹249 Cr
₹94 Cr	₹60 Cr	₹40 Cr	₹30 Cr	₹21 Cr	₹14 Cr	₹18 Cr
₹133 Cr	₹157 Cr	₹310 Cr	₹306 Cr	₹254 Cr	₹168 Cr	₹145 Cr
-₹26 Cr	-₹25 Cr	-₹35 Cr	-₹53 Cr	-₹13 Cr	-₹13 Cr	-₹11 Cr
₹1203 Cr	₹1084 Cr	₹648 Cr	₹546 Cr	₹324 Cr	₹265 Cr	₹188 Cr
₹24 Cr	₹18 Cr	₹14 Cr	₹10 Cr	₹7 Cr	₹5 Cr	₹4 Cr
₹1334 Cr	₹1235 Cr	₹937 Cr	₹809 Cr	₹572 Cr	₹425 Cr	₹327 Cr
—	—	—	—	—	—	—
₹149 Cr	₹127 Cr	₹133 Cr	₹101 Cr	₹89 Cr	₹75 Cr	₹64 Cr
₹280 Cr	₹329 Cr	₹233 Cr	₹189 Cr	₹95 Cr	₹58 Cr	₹64 Cr
₹0	₹0	₹15 Cr	₹5 Cr	₹10 Cr	₹10 Cr	₹12 Cr
₹32 Cr	₹22 Cr	₹19 Cr	₹7 Cr	₹12 Cr	₹8 Cr	₹6 Cr
₹461 Cr	₹478 Cr	₹400 Cr	₹301 Cr	₹206 Cr	₹150 Cr	₹146 Cr
₹3915 Cr	₹3640 Cr	₹2716 Cr	₹1770 Cr	₹1012 Cr	₹774 Cr	₹740 Cr
₹68 Cr	₹73 Cr	₹19 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹8 Cr
₹157 Cr	₹247 Cr	₹388 Cr	₹356 Cr	₹290 Cr	₹185 Cr	₹162 Cr
—	—	—	—	—	—	—
₹3764 Cr	₹3397 Cr	₹2399 Cr	₹1794 Cr	₹1082 Cr	₹854 Cr	₹738 Cr
₹891 Cr	₹871 Cr	₹653 Cr	₹501 Cr	₹381 Cr	₹279 Cr	₹188 Cr
₹3 Cr	₹3 Cr	₹0	₹0	₹0	₹0	₹0
₹2870 Cr	₹2523 Cr	₹1746 Cr	₹1293 Cr	₹701 Cr	₹575 Cr	₹551 Cr
₹234 Cr	₹144 Cr	₹114 Cr	₹98 Cr	₹28 Cr	₹11 Cr	₹8 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹70 L
₹0	₹0	₹0	₹0	₹0	₹0	₹70 L
₹108 Cr	₹106 Cr	₹93 Cr	₹67 Cr	₹55 Cr	₹34 Cr	₹35 Cr
₹120 Cr	₹69 Cr	₹0	₹0	₹0	₹0	₹0
₹3342 Cr	₹2851 Cr	₹1958 Cr	₹1460 Cr	₹785 Cr	₹619 Cr	₹594 Cr
—	—	—	—	—	—	—
₹152 Cr	₹264 Cr	₹471 Cr	₹34 Cr	₹0	₹0	₹0
₹94 Cr	₹80 Cr	₹52 Cr	₹36 Cr	₹33 Cr	₹28 Cr	₹33 Cr
₹161 Cr	₹124 Cr	₹97 Cr	₹76 Cr	₹57 Cr	₹47 Cr	₹52 Cr
₹129 Cr	₹251 Cr	₹125 Cr	₹149 Cr	₹117 Cr	₹65 Cr	₹44 Cr
₹13 Cr	₹51 Cr	₹5 Cr	₹6 Cr	₹3 Cr	₹3 Cr	₹3 Cr
₹23 Cr	₹19 Cr	₹9 Cr	₹9 Cr	₹18 Cr	₹12 Cr	₹12 Cr
₹573 Cr	₹789 Cr	₹759 Cr	₹310 Cr	₹227 Cr	₹154 Cr	₹146 Cr
₹111 Cr	₹311 Cr	₹359 Cr	₹9 Cr	₹21 Cr	₹4 Cr	-₹6 L
₹3915 Cr	₹3640 Cr	₹2716 Cr	₹1770 Cr	₹1012 Cr	₹774 Cr	₹740 Cr
₹64	₹59	₹1,429	₹792	₹310	₹269	₹363
₹64	₹59	₹48	₹26	₹10	₹9	₹12

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
₹249 Cr	₹160 Cr	₹141 Cr	₹84 Cr	₹57 Cr	-₹48 Cr	-₹11 Cr
₹373 Cr	₹331 Cr	₹233 Cr	₹197 Cr	₹138 Cr	₹145 Cr	₹139 Cr
-₹48 Cr	-₹98 Cr	₹5 Cr	-₹13 Cr	-₹15 Cr	₹10 Cr	-₹9 Cr
₹574 Cr	₹394 Cr	₹378 Cr	₹268 Cr	₹180 Cr	₹107 Cr	₹120 Cr
₹519 Cr	₹357 Cr	₹346 Cr	₹233 Cr	₹164 Cr	₹99 Cr	₹103 Cr
-₹308 Cr	-₹750 Cr	-₹914 Cr	-₹509 Cr	-₹155 Cr	-₹37 Cr	-₹80 Cr
-₹220 Cr	₹382 Cr	₹553 Cr	₹303 Cr	₹35 Cr	-₹37 Cr	-₹73 Cr
-₹10 Cr	-₹11 Cr	-₹15 Cr	₹27 Cr	₹44 Cr	₹25 Cr	-₹50 Cr
₹100 Cr	₹112 Cr	₹127 Cr	₹100 Cr	₹55 Cr	₹39 Cr	₹94 Cr
₹0	₹0	₹0	₹0	₹0	-₹9 Cr	-₹6 Cr
₹91 Cr	₹100 Cr	₹112 Cr	₹127 Cr	₹100 Cr	₹55 Cr	₹39 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Dr. Agarwal's Health Care Share Price

486.85+0.00 (+0.54%)

-0.72% past 1 Year

Shareholding summary

Promoters

32.34%

FII

37.91%

DII

1.7%

6.02%

Others

22.03%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
32.34%	32.36%	32.39%	32.42%	32.42%	32.45%
37.91%	37.87%	37.97%	38.02%	39.15%	40.49%
1.70%	1.96%	2.01%	2.07%	1.53%	1.37%
6.02%	5.87%	5.77%	5.85%	4.91%	3.84%
22.03%	21.94%	21.86%	21.64%	21.99%	21.85%

Bulk & block deals

Name

Icici Prudential Mutual Fund

Polar Capital Funds Plc-Healthcare Opportunities Fund

Invesco Mutual Fund

Marwadi Chandarana Intermediaries Brokers Private Limited

Allianz Global Investors Gmbh Acting On Behalf Of Allianz Eee Fonds

Hyperion Investments Pte. Ltd.

Claymore Investments (Mauritius) Pte.ltd.

Marwadi Chandarana Intermediaries Brokers Private Limited

Goldman Sachs Bank Europe Se - Odi

Goldman Sachs (Singapore) Pte - Odi

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
12 Aug 2026	Purchase	311.21 Cr	₹501	62.12 L	Bulk	1.959401	NSE
12 Aug 2026	Purchase	181.68 Cr	₹501	36.26 L	Bulk	1.143883	NSE
12 Aug 2026	Purchase	179.93 Cr	₹504.64	35.65 L	Bulk	1.124652	NSE
12 Aug 2026	Purchase	98.47 Cr	₹502.46	19.60 L	Bulk	0.618185	NSE
12 Aug 2026	Purchase	88.78 Cr	₹501	17.72 L	Bulk	0.558984	NSE
12 Aug 2026	Sell	1,210.49 Cr	₹501.03	2.42 Cr	Bulk	7.620821	NSE
12 Aug 2026	Sell	797.45 Cr	₹501.54	1.59 Cr	Bulk	5.015358	NSE
12 Aug 2026	Sell	33.25 Cr	₹510.96	6.51 L	Bulk	0.205285	NSE
02 Sep 2025	Purchase	71.65 Cr	₹433.25	16.54 L	Bulk	0.521637	NSE
02 Sep 2025	Sell	71.65 Cr	₹433.25	16.54 L	Bulk	0.521637	NSE

Insider trading & SAST

Client name

Claymore Investments (Mauritius) Pte Ltd

Icici Prudential Mutual Fund

Invesco Mutual Fund

Hyperion Investments Pte Ltd

Dr. Anosh Agarwal

Dr Athiya Agarwal

Dr. Athiya Agarwal

Dr Anosh Agarwal

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
26 Aug 2026	Other	Disposal	5.02	15.04	—	1.59 Cr	12 Aug 2026	Market	4,76,71,770	SAST	29(2)	—
26 Aug 2026	Other	Acquisition	5.36	5.36	—	1.70 Cr	12 Aug 2026	Market	1,69,99,999	SAST	29(1)	—
26 Aug 2026	Other	Acquisition	2.18	5.21	—	69.38 L	12 Aug 2026	Market	1,65,25,136	SAST	29(1)	—
26 Aug 2026	Other	Disposal	7.62	15.47	—	2.42 Cr	12 Aug 2026	Market	4,90,33,988	SAST	29(2)	—
13 Apr 2026	Promoter	Disposal	0.67	4.69	—	21.15 L	04 Mar 2026	Off Market / Inter se transfer	1,48,57,920	SAST	29(2)	—
13 Apr 2026	Promoter	Acquisition	0.45	4.45	—	14.42 L	19 Mar 2026	Off Market / Inter se transfer	1,41,03,543	SAST	29(2)	—
13 Apr 2026	Other	Acquisition	0.67	—	—	21.15 L	04 Mar 2026	-	—	SAST	10(6)	—
13 Apr 2026	Promoter	Acquisition	0.46	—	—	14.42 L	13 Mar 2026	—	—	SAST	10(5)	—
13 Apr 2026	Promoter	Acquisition	0.67	4	—	21.15 L	04 Mar 2026	Off Market / Inter se transfer	1,26,61,975	SAST	29(2)	—
13 Apr 2026	Promoter	Disposal	0.45	4.23	—	14.42 L	19 Mar 2026	Off Market / Inter se transfer	1,34,16,352	SAST	29(2)	—

Dr. Agarwal's Health Care Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Dr. Agarwal's Health Care Share Price

Dr. Agarwal's Health Care Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Dr. Agarwal's Health Care Share Price

Dr. Agarwal's Health Care Share Price

Oscillators

Moving averages

Dr. Agarwal's Health Care Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Dr. Agarwal's Health Care Share Price

Corporate Actions

Company details

Dr. Agarwal's Health Care Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Dr. Agarwal's Health Care Share Price

News

Dr. Agarwal's Health Care plans Delhi NCR expansion over next 2 to 3 years

Dr Agarwal's Health Care to host analyst and investor meet on 16 September

Dr. Agarwal Health Care reports higher Q1 EBITDA and margin

Dr. Agarwal'S Health Care posts strong Q1 revenue growth on robust operations

Dr. Agarwal's Health Care reports higher Q1 net profit year on year

Dr. Agarwal'S Health Care to host Q1 FY27 earnings call on August 4

Dr. Agarwal's Health Care’s arm invests $2,00,000 in Orbit Health Care ETH

Dr. Agarwal's Health - Quaterly Results

Dr. Agarwal's Health reports Profit after tax of 10.60 Crores, in the March 2026 quarter

Dr. Agarwals Health Care informs about updates

Dr. Agarwal's Health Care Terminates Idearx Associate Status Effective March 30, 2026, Retains 14.54% Stake.

Dr. Agarwals Health Care informs about disclosures

Dr. Agarwals Health Care informs about disclosure

Morgan Stanley Maintains Overweight on Dr Agarwal’s Health Care with Rs 596 Target Price.

Dr. Agarwal's Health Care Q3 FY26 EBITDA Rises 27% YoY to Rs 140 Cr, Margin Expands to 27.17%.

Dr. Agarwal's Health Care Q3FY26 Net Profit Rises 51% YoY to Rs 33.70 Crores on 23% Revenue Growth.

Dr. Agarwal's Health reports Profit after tax of 14.06 Crores, in the December 2025 quarter

Dr Agarwals Health Care informs about disclosure

Dr. Agarwals Health Care informs about investor presentation

Dr. Agarwal's Health reports Profit after tax of 4.68 Crores, in the September 2025 quarter

Dr. Agarwal's Health Care Ltd Share Price Today

Dr. Agarwal's Health Care Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator